On Tuesday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) was -4.42% drop from the session before settling in for the closing price of $8.59. A 52-week range for RCKT has been $8.25 – $28.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 14.70%. With a float of $98.97 million, this company’s outstanding shares have now reached $106.45 million.
The extent of productivity of a business whose workforce counts for 299 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Rocket Pharmaceuticals Inc stocks. The insider ownership of Rocket Pharmaceuticals Inc is 7.18%, while institutional ownership is 101.02%. The most recent insider transaction that took place on Feb 25 ’25, was worth 69,109. In this transaction an insider of this company sold 6,532 shares at a rate of $10.58, taking the stock ownership to the 237,638 shares. Before that another transaction happened on May 17 ’24, when Company’s insider sold 2,754 for $23.35, making the entire transaction worth $64,306. This insider now owns 169,659 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 73.89% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
You can see what Rocket Pharmaceuticals Inc (RCKT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.73, a number that is poised to hit -0.61 in the next quarter and is forecasted to reach -1.54 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
The latest stats from [Rocket Pharmaceuticals Inc, RCKT] show that its last 5-days average volume of 1.39 million was inferior to 1.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 19.01%. Additionally, its Average True Range was 0.57.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 1.39%, which indicates a significant decrease from 4.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.66% in the past 14 days, which was lower than the 52.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.52, while its 200-day Moving Average is $16.62. Now, the first resistance to watch is $8.56. This is followed by the second major resistance level at $8.91. The third major resistance level sits at $9.16. If the price goes on to break the first support level at $7.96, it is likely to go to the next support level at $7.71. The third support level lies at $7.36 if the price breaches the second support level.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
There are 106,630K outstanding shares of the company, which has a market capitalization of 875.43 million. As of now, sales total 0 K while income totals -258,750 K. Its latest quarter income was 0 K while its last quarter net income were -60,330 K.
